These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 20862776)
1. Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion. Yu A; Wang H; Wang J; Cao F; Gao Y; Cui J; Zhai G J Pharm Sci; 2011 Mar; 100(3):933-41. PubMed ID: 20862776 [TBL] [Abstract][Full Text] [Related]
2. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo. Quan DQ; Xu GX Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241 [TBL] [Abstract][Full Text] [Related]
3. Enhanced oral bioavailability of puerarin using microemulsion vehicle. Wu H; Lu C; Zhou A; Min Z; Zhang Y Drug Dev Ind Pharm; 2009 Feb; 35(2):138-44. PubMed ID: 19040180 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565 [TBL] [Abstract][Full Text] [Related]
5. Formulation development and pharmacokinetics of puerarin self-emulsifying drug delivery systems. Dong-Qin Q; Gui-Xia X; Xiang-Gen W PDA J Pharm Sci Technol; 2007; 61(1):37-43. PubMed ID: 17390702 [TBL] [Abstract][Full Text] [Related]
6. N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation. Liao D; Liu X; Dai W; Tang T; Ou G; Zhang K; Han M; Kang R; Yang S; Xiang D Drug Deliv; 2015; 22(4):516-21. PubMed ID: 24467620 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach. Tang TT; Hu XB; Liao DH; Liu XY; Xiang DX Int J Nanomedicine; 2013; 8():4415-26. PubMed ID: 24277986 [TBL] [Abstract][Full Text] [Related]
8. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery. Zhang Y; Wang R; Wu J; Shen Q Int J Pharm; 2012 May; 427(2):337-44. PubMed ID: 22366381 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs]. Chen XX; Yuan S; Li G; Liang YY; Zhou X; Xie CS; Long CF Zhong Yao Cai; 2011 May; 34(5):750-3. PubMed ID: 21954564 [TBL] [Abstract][Full Text] [Related]
10. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations. Wu JY; Li YJ; Han M; Hu XB; Yang L; Wang JM; Xiang DX Drug Dev Ind Pharm; 2018 Aug; 44(8):1336-1341. PubMed ID: 29513046 [TBL] [Abstract][Full Text] [Related]
11. [Preparation of puerarin liposome and its oral absorption in rat]. Gu YZ; Zhou W; Zhai GX Zhong Yao Cai; 2007 Aug; 30(8):970-3. PubMed ID: 18074848 [TBL] [Abstract][Full Text] [Related]
12. Preparation and In Vitro/In Vivo Evaluation of Puerarin Solid Self-Microemulsifying Drug Delivery System by Spherical Crystallization Technique. Cheng G; Hu R; Ye L; Wang B; Gui Y; Gao S; Li X; Tang J AAPS PharmSciTech; 2016 Dec; 17(6):1336-1346. PubMed ID: 26694058 [TBL] [Abstract][Full Text] [Related]
13. [Preparation of puerarin solid self-microemulsion]. Yu AH; Zhai GX; Cui J; Liu H Zhong Yao Cai; 2006 Aug; 29(8):834-8. PubMed ID: 17076244 [TBL] [Abstract][Full Text] [Related]
14. Development of udenafil-loaded microemulsions for intranasal delivery: in vitro and in vivo evaluations. Cho HJ; Ku WS; Termsarasab U; Yoon I; Chung CW; Moon HT; Kim DD Int J Pharm; 2012 Feb; 423(2):153-60. PubMed ID: 22209996 [TBL] [Abstract][Full Text] [Related]
15. Studies on preparation and absolute bioavailability of a self-emulsifying system containing puerarin. Quan DQ; Xu GX; Wu XG Chem Pharm Bull (Tokyo); 2007 May; 55(5):800-3. PubMed ID: 17473473 [TBL] [Abstract][Full Text] [Related]
16. Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile. Li W; Wu J; Zhang J; Wang J; Xiang D; Luo S; Li J; Liu X Drug Deliv; 2018 Nov; 25(1):827-837. PubMed ID: 29587545 [TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion. Yue PF; Yuan HL; Yang M; You RH; Cong LB; Zhu J; Wang Q; Zhu WF; Xiao XH PDA J Pharm Sci Technol; 2008; 62(1):32-45. PubMed ID: 18402366 [TBL] [Abstract][Full Text] [Related]
18. Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient. Hirunpanich V; Sato H Eur J Pharm Biopharm; 2009 Oct; 73(2):247-52. PubMed ID: 19560537 [TBL] [Abstract][Full Text] [Related]
19. Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization, ex vivo and in vivo characterization. Gannu R; Palem CR; Yamsani VV; Yamsani SK; Yamsani MR Int J Pharm; 2010 Mar; 388(1-2):231-41. PubMed ID: 20060457 [TBL] [Abstract][Full Text] [Related]
20. Intranasal microemulsion of sildenafil citrate: in vitro evaluation and in vivo pharmacokinetic study in rabbits. Elshafeey AH; Bendas ER; Mohamed OH AAPS PharmSciTech; 2009; 10(2):361-7. PubMed ID: 19333762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]